Welcome to our dedicated page for Travelers Compan SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for The Travelers Companies, Inc. (NYSE: TRV), a property casualty insurer that offers auto, home and business coverage. Travelers’ filings give investors and analysts detailed information about its financial condition, capital structure, risk profile and governance.
Travelers uses current reports on Form 8-K to disclose material events and updates. For example, a Form 8-K filed on October 16, 2025, furnishes a press release and financial supplement reporting the company’s results for the quarter ended September 30, 2025. Another Form 8-K filed on July 24, 2025, describes an underwriting agreement for the issuance and sale of senior notes due 2035 and 2055, and confirms that Travelers’ common stock trades on the New York Stock Exchange under the symbol TRV.
In addition to 8-Ks, Travelers files annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain segment information for Business Insurance, Bond & Specialty Insurance and Personal Insurance, as well as discussions of underwriting results, catastrophe losses, reserve development, net investment income and capital management. Proxy statements on Schedule 14A and beneficial ownership or insider transaction reports on forms such as Form 4 provide further insight into governance and executive and director share activity.
On Stock Titan, Travelers’ SEC filings are updated from the EDGAR system and presented with AI-powered summaries that highlight key points from lengthy documents. These summaries are designed to help users quickly understand the main drivers of performance, capital actions such as debt issuance, and other material disclosures without reading every page of the underlying filing.
The Travelers Companies (TRV) vice chairman reported option exercises and open‑market sales. From 11/07–11/11/2025, the insider exercised 7,000 stock options at an exercise price of $139.83 and sold 7,000 common shares in multiple transactions at prices including $280, $281, $282, a weighted average of $283.89, $285, and $286.
Following these transactions, directly held shares were 255,085.534, with an additional 1,710.706 shares listed under a 401(k) Plan. The filing notes shares held by a spouse and a trust for a stepson are disclaimed for beneficial ownership. Derivative holdings show 2,000 stock options remaining.
TRV: A holder filed a Form 144 notice to sell 4,000 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $1,138,780.00. The notice lists an approximate sale date of 11/11/2025 on the NYSE.
The securities were acquired on 11/11/2025 via an option granted on 02/02/2021, with cash payment on 11/11/2025. As context, 223,063,417 shares were outstanding. Recent activity by the same seller includes 2,000 shares sold on 08/22/2025 for $557,000.00, 1,000 shares on 11/07/2025 for $280,000.00, and 2,000 shares on 11/10/2025 for $563,000.00.
The notice affirms the seller does not know of undisclosed material adverse information.
TRV: A shareholder filed a Form 144 notice to sell up to 2,000 common shares, with an aggregate market value of $563,000. The approximate sale date is 11/10/2025 through Fidelity Brokerage Services LLC on the NYSE. The shares were acquired via an option granted on 02/02/2021 and paid in cash on 11/10/2025.
In the past three months, the filer sold 2,000 shares on 08/22/2025 for $557,000 and 1,000 shares on 11/07/2025 for $280,000. Shares outstanding were 223,063,417; this is a baseline figure, not the amount being sold.
TRV — Notice of proposed sale under Rule 144. A holder filed a Form 144 to sell up to 1,000 shares of common stock with an aggregate market value of $280,000. The filing lists an approximate sale date of November 7, 2025, with sales to be made on the NYSE through Fidelity Brokerage Services LLC.
The disclosure also notes prior sales in the last three months: William H. Heyman sold 2,000 common shares on August 22, 2025 for gross proceeds of $557,000.
The Travelers Companies (TRV) EVP & CFO reported an option exercise and share sale. On 11/06/2025, the officer exercised 25,000 stock options at $139.83 per share and sold 25,000 common shares at a weighted average price of $278.2502.
Following these transactions, the officer beneficially owned 26,931.82 shares directly. Derivative holdings included 11,037 stock options remaining. The sales price reflects multiple trades within the $278.25 to $278.252 range.
Travelers (TRV) filed a Form 144 notice for a proposed sale of 25,000 shares of common stock. The filing lists an aggregate market value of $6,956,254.49, with Fidelity Brokerage Services as broker and the NYSE as the exchange. The approximate date of sale is 11/06/2025. The shares relate to an option granted on 02/02/2021, with cash payment on 11/06/2025.
This is a notice by a person for whose account the securities are to be sold under Rule 144 and does not represent an issuance by the company.
The Travelers Companies (TRV) Form 4: an executive officer (EVP & President, Personal Insurance) exercised 8,572 stock options at $132.58 on 10/28/2025 and sold 6,742 shares at a weighted average price of $270.5946 and 1,830 shares at a weighted average price of $271.2455 the same day. Following these transactions, direct holdings were 33,638.031 shares, with an additional 1,874.659 shares held indirectly in a 401(k) plan. The option grant covered 8,572 underlying shares and 30,000 derivative securities remained beneficially owned after the transactions.
TRV: A shareholder filed a Form 144 notice to sell up to 8,572 shares of common stock with an aggregate market value $2,320,728.19. The proposed sale is listed for 10/28/2025 through Fidelity Brokerage Services LLC on the NYSE. Shares outstanding were 223,063,417.
The notice indicates the shares derive from an option granted on 02/04/2020 and acquired on 10/28/2025 with cash payment. It also reports a prior sale by Michael Klein of 10,000 shares on 08/04/2025 for $2,619,855.
The Travelers Companies (TRV) reported stronger Q3 results. Total revenues were $12,470 million, up from $11,904 million a year ago, driven by higher premiums of $11,135 million and net investment income of $1,033 million. Net income rose to $1,888 million from $1,260 million, and diluted EPS increased to $8.24 from $5.42.
Profitability benefited from lower catastrophe losses of $402 million versus $939 million in the prior year period and higher segment income of $1,964 million versus $1,304 million. By segment this quarter, premiums were $5,700 million in Business Insurance, $1,042 million in Bond & Specialty, and $4,393 million in Personal Insurance.
Year to date, operating cash flow was $7,921 million. The company repurchased $625 million of shares in the quarter and paid $250 million in common dividends. Shareholders’ equity increased to $31,609 million as accumulated other comprehensive loss narrowed. TRV also agreed to sell its Canadian personal and most commercial insurance business for approximately $2.4 billion, retaining surety in Canada; the sale is subject to approvals and expected to close in the first quarter of 2026.
The Travelers Companies, Inc. (TRV) announced quarterly results for the period ended September 30, 2025, and made its third‑quarter financial supplement available on its website. The company furnished a press release and the supplement as Exhibits 99.1 and 99.2.
The materials are provided as furnished, not filed, under Form 8‑K General Instruction B.2.